$SLDB

Solid Biosciences Inc

$SLDB

Solid Biosciences Inc

Past 12mo:6mentions1voices

All voices6 mentions since Sep 2025calls only

Loading price chart…

Frequently asked

Who mentions $SLDB most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $SLDB most — 6 mentions in the past 12 months.

When was $SLDB first mentioned on Surfaced?

The earliest tracked mention of $SLDB in the Surfaced archive was on Sep 8, 2025.

How many voices track $SLDB?

1 FinTwit voice has mentioned $SLDB 6 times in the past 12 months.

What kind of voices mention $SLDB most?

$SLDB is mentioned most by Biotech voices on Surfaced.

Recent mentions

6 mentions

@adamfeuersteinMay 14, 2026 · 12:48 PM

@pemulisking Approval standard is the biggest overhang, I think. $RGNX single-arm study using correlative analysis to link microD expression to muscle benefit vs $SLDB going with a placebo controlled study to do the same.

Open on X

@adamfeuersteinApr 16, 2026 · 1:40 PM

@bradloncar Funny how you never see the videos of kids who can't walk up stairs or get up from the floor after taking a gene therapy. Sure, videos like the one shared by $SLDB and previously by $SRPT are heartwarming and encouraging, but they are not data.

Open on X

@adamfeuersteinFeb 18, 2026 · 5:07 PM

"Prasad" stocks today: $CAPR +11%, $REPL +11%, $QURE +9%. $RGNX $SLDB up, too

Open on X

@adamfeuersteinJan 12, 2026 · 5:07 PM

$SRPT Elevidys Q4 sales $110M vs consensus $120M At his #JPM26 presentation, CEO Doug Ingram notes 80% of addressable ambulatory DMD patients remain untreated. He sees this a huge opportunity for Elevidys, but I will note it's also the same for $SLDB and $RGNX and others developing next-gen gene therapies.

Open on X

@adamfeuersteinOct 8, 2025 · 4:06 PM

Duchenne gene therapy stocks today: $SLDB +22% $RGNX +14% $SRPT +1%

Open on X

@adamfeuersteinSep 8, 2025 · 8:25 PM

@bio_clouseau @MauriceOnTW I will get more info and confirm, but I believe $SLDB has said previously that it planned a randomized ex-US study.

Open on X